摘要
目的研究富马酸比索洛尔片应用在治疗急性心肌梗死中的效果。方法需选取2018年4月-2019年5月在本院接受急性心肌梗死治疗的332例患者作为本次研究活动的观察对象,并遵循随机数字表法分为对照组(166例,进行常规治疗)与试验组(166例,采用富马酸比索洛尔片进行治疗),比较两组的LVEF(左心室射血分数)、血浆脑钠尿肽以及治疗安全性。结果(1)分组治疗后,试验组患者的LVEF指标明显大于对照组,且试验组患者的血浆脑钠尿肽水平低于对照组,P<0.05;(2)试验组患者的不良反应率(4.76%)小于对照组(28.57%),P<0.05。结论给予急性心肌梗死患者富马酸比索洛尔片治疗,疗效极佳,且能改善患者心功能,治疗安全性较高。
Objective To study the e ffect of bisoprolol fumarate tablets in the treatment of acute myocardial infarction.Methods 332 patients who underwent acute myocardial infarction in our hospital from April 2018 to May 2019 were enrolled as subjects of this study and were randomized to a control group(166 patients,routine treatment)and the experimental group(166 cases,treated with bisoprolol fumarate tablets),compared LVEF(left ventricular ejection fraction),plasma brain natriuretic peptide and treatment safety.Results(1)After group treatment,the LVEF index of the experimental group was significantly higher than that of the control group,and the plasma brain natriuretic peptide level of the experimental group was lower than that of the control group,P<0.05;(2)the adverse reaction rate of the experimental group(4.76%)was smaller than the control group(28.57%),P<0.05.Conclusion The treatment of bisoprolol fumarate tablets in patients with acute myocardial infarction is very effective and can improve the heart function of patients with high safety.
作者
李建飞
宋明哲
阿拉腾其木格
俞波
钟梅
高江峰
杨发
王智勇
LI Jianfei;SONG Mingzhe;Alatengqimuge;YU Bo;ZHONG Mei;GAO Jiangfeng;YANG Fa;WANG Zhiyong(Department of Emergency Cardiology,People's Hospital of Inner Mongolia Autonomous Region,Hohhot Inner Mongolia 010000,China)
出处
《中国卫生标准管理》
2019年第20期83-85,共3页
China Health Standard Management
关键词
富马酸比索洛尔片
急性心肌梗死
临床效果
左心室射血分数
血浆脑钠尿肽
安全性
bisoprolol fumarate tablets
acute myocardial infarction
clinical effect
left ventricular ejection fraction
plasma brain natriuretic peptide
safety
